Literature DB >> 22116740

ASSOCIATIONS BETWEEN POST-TRAUMATIC STRESS DISORDER SYMPTOMS AND ALCOHOL AND OTHER DRUG PROBLEMS: IMPLICATIONS FOR SOCIAL WORK PRACTICE.

Shelly A Wiechelt1, Brenda A Miller, Nancy J Smyth, Eugene Maguin.   

Abstract

This study examines the associations between alcohol and other drug problems (AOD) and post-traumatic stress disorder (PTSD) symptoms in 499 women recruited from outpatient treatment programs for AOD problems and the general community in western New York. The women were divided into three groups: no-AOD, past-AOD, and current-AOD. The current-AOD group was further subdivided into groups based on alcohol, marijuana, and cocaine misuse. Group comparisons on PTSD symptoms revealed that the current-AOD group experienced more PTSD symptoms than the no-AOD and past-AOD groups. The alcohol and cocaine misuse groups experienced more PTSD symptoms overall and for each symptom cluster than the no-AOD and past-AOD groups, but did not differ from each other or the marijuana group on PTSD symptoms. These findings suggest that individuals who have AOD problems should be assessed for PTSD symptoms and provided with trauma-specific interventions when warranted. Trauma-informed care may benefit those in AOD treatment. Individuals who have PTSD symptoms should be assessed for AOD problems as well.

Entities:  

Year:  2011        PMID: 22116740      PMCID: PMC3221512          DOI: 10.1080/09503153.2011.597200

Source DB:  PubMed          Journal:  Practice (Birm)        ISSN: 0950-3153


  20 in total

Review 1.  Misunderstanding analysis of covariance.

Authors:  G A Miller; J P Chapman
Journal:  J Abnorm Psychol       Date:  2001-02

2.  Effects of varying diagnostic criteria for posttraumatic stress disorder are endorsing the concept of partial PTSD.

Authors:  M Schützwohl; A Maercker
Journal:  J Trauma Stress       Date:  1999-01

3.  Efficacy of brief coping skills interventions that match different personality profiles of female substance abusers.

Authors:  P J Conrod; S H Stewart; R O Pihl; S Côté; V Fontaine; M Dongier
Journal:  Psychol Addict Behav       Date:  2000-09

4.  Investigations of causal pathways between PTSD and drug use disorders.

Authors:  H D Chilcoat; N Breslau
Journal:  Addict Behav       Date:  1998 Nov-Dec       Impact factor: 3.913

Review 5.  Developing effective treatments for posttraumatic disorders among people with severe mental illness.

Authors:  S D Rosenberg; K T Mueser; M J Friedman; P G Gorman; R E Drake; R M Vidaver; W C Torrey; M K Jankowski
Journal:  Psychiatr Serv       Date:  2001-11       Impact factor: 3.084

6.  Vulnerability to assaultive violence: further specification of the sex difference in post-traumatic stress disorder.

Authors:  N Breslau; H D Chilcoat; R C Kessler; E L Peterson; V C Lucia
Journal:  Psychol Med       Date:  1999-07       Impact factor: 7.723

7.  Comorbidity, impairment, and suicidality in subthreshold PTSD.

Authors:  R D Marshall; M Olfson; F Hellman; C Blanco; M Guardino; E L Struening
Journal:  Am J Psychiatry       Date:  2001-09       Impact factor: 18.112

8.  Gender and posttraumatic stress: sexual violence as an explanation for women's increased risk.

Authors:  Lilia M Cortina; Sheryl Pimlott Kubiak
Journal:  J Abnorm Psychol       Date:  2006-11

9.  Implementing trauma-informed alcohol and other drug and mental health services for women: lessons learned in a multisite demonstration project.

Authors:  Laurie S Markoff; Beth Glover Reed; Roger D Fallot; Denise E Elliott; Paula Bjelajac
Journal:  Am J Orthopsychiatry       Date:  2005-10

Review 10.  Functional associations among trauma, PTSD, and substance-related disorders.

Authors:  S H Stewart; R O Pihl; P J Conrod; M Dongier
Journal:  Addict Behav       Date:  1998 Nov-Dec       Impact factor: 3.913

View more
  1 in total

1.  PTSD Symptom Severities, Interpersonal Traumas, and Benzodiazepines Are Associated with Substance-Related Problems in Trauma Patients.

Authors:  Jeffrey Guina; Ramzi W Nahhas; Adam J Goldberg; Seth Farnsworth
Journal:  J Clin Med       Date:  2016-08-10       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.